DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 1 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $94,289,962 | -2.2% | 5,994,276 | +0.3% | 0.00% | 0.0% |
| Q4 2023 | $96,397,171 | +39.1% | 5,976,266 | +9.7% | 0.00% | 0.0% |
| Q3 2023 | $69,311,356 | -10.0% | 5,449,006 | -0.3% | 0.00% | 0.0% |
| Q2 2023 | $76,989,425 | -10.1% | 5,467,999 | -1.4% | 0.00% | -33.3% |
| Q1 2023 | $85,670,062 | -3.6% | 5,544,988 | +2.3% | 0.00% | 0.0% |
| Q4 2022 | $88,834,209 | -7.9% | 5,420,025 | +4.0% | 0.00% | 0.0% |
| Q3 2022 | $96,419,000 | +32.6% | 5,211,863 | -5.7% | 0.00% | +50.0% |
| Q2 2022 | $72,704,000 | +61.9% | 5,528,742 | +14.1% | 0.00% | +100.0% |
| Q1 2022 | $44,917,000 | +21.1% | 4,845,376 | +27.6% | 0.00% | 0.0% |
| Q4 2021 | $37,102,000 | -70.4% | 3,797,569 | +2.8% | 0.00% | -75.0% |
| Q3 2021 | $125,554,000 | -6.8% | 3,694,905 | +0.4% | 0.00% | 0.0% |
| Q2 2021 | $134,768,000 | -13.8% | 3,681,213 | +5.6% | 0.00% | -20.0% |
| Q1 2021 | $156,267,000 | -19.7% | 3,485,003 | +2.2% | 0.01% | -16.7% |
| Q4 2020 | $194,599,000 | +16.4% | 3,409,858 | +4.6% | 0.01% | 0.0% |
| Q3 2020 | $167,216,000 | -9.4% | 3,259,572 | +5.5% | 0.01% | -14.3% |
| Q2 2020 | $184,488,000 | +110.7% | 3,089,206 | +45.2% | 0.01% | +75.0% |
| Q1 2020 | $87,571,000 | -30.3% | 2,127,101 | +5.4% | 0.00% | -20.0% |
| Q4 2019 | $125,669,000 | +83.2% | 2,019,077 | -0.1% | 0.01% | +66.7% |
| Q3 2019 | $68,608,000 | +98.6% | 2,021,468 | +32.0% | 0.00% | +200.0% |
| Q2 2019 | $34,543,000 | +22.0% | 1,531,844 | +25.6% | 0.00% | 0.0% |
| Q1 2019 | $28,316,000 | +15.0% | 1,219,974 | +4.0% | 0.00% | 0.0% |
| Q4 2018 | $24,625,000 | -5.9% | 1,173,245 | +73.6% | 0.00% | 0.0% |
| Q3 2018 | $26,167,000 | +12.5% | 675,818 | +14.3% | 0.00% | 0.0% |
| Q2 2018 | $23,258,000 | +132.2% | 591,064 | +18.2% | 0.00% | – |
| Q1 2018 | $10,018,000 | +21.6% | 499,879 | +37.5% | 0.00% | – |
| Q4 2017 | $8,241,000 | +4776.3% | 363,483 | +3989.6% | 0.00% | – |
| Q3 2017 | $169,000 | – | 8,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 50,000 | $759 | 0.00% |